IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
PIK3CA Mutated Advanced Solid Tumors
Novartis Pharmaceuticalsmonoclonal_antibodyPhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 30/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the PIK3CA Mutated Advanced Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Alpelisib Novartis Pharmaceuticals | Phase 1/2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →